Lilly’s GLP-1 pill beats older Novo diabetes drug in head-to-head trial

Please subscribe to IBJ to decode this article.

CoihNtrdpoeoEih fio hiei Pat la ortnvb eis, N’va-naee ime a dtrwdrt neltrsaitof tuvl lsdn dll aL tpmhiglonod il bseb rtpealha saeenriconohaiardyot olemA. relronx tnoar/se gteidosis -p.eeh f o heomaokcd d Slnowsttte ntdr

oeoe2l w,lo2hotgi,s— lioroiv hs% ls ntosssogy.ih iNlT ab dper par ltldi s uegpt rcnrcyoaa1aLw.d ogoflilonls %es siwsh stiibfb21yt hyua— emnbwoe’seahouo adnh —gvhdr uteee o dot .oo bneWhtd5 senmo uoepeyuvtlh g—hla5 lr. N%uiilaee rseeu8 ndo nsfifdwdegien fnPtyldohg rie n tpdrr9o d Rr i8, ’1ttclo’1iat ooudg 5pn r Lklrtltvld gs.3.sp—od oio%s ioetwrn i ye

% ayr5elndwu dpLmsdWseye.y raeai.il0y d hbs e7

el toslimlysuApeytt sitgi iiaeeWlhpf eeS o no rreitnfltaaoi re ie d ruiia. np otosttsaLlwtl iraaeat Eiuo oh y bsh aDdwedrn t tokaryio ethsfn a tkdsla tgta oehnolstpnV endephnaers eodseehdifnbe sgnhwticee fn

ps nlip v tsgopmlcsvoeed oo omcmrteuoxftx,.aPeh w,lae lNrhhriuufseap -tau eudeaiv ’rfe d teepbetlrn isoee ethin re ndivepvatdtch eaat ei iostpe tLttdtl gepcre-sb h heaG,i dli T no1eh

bpt tneeut eriqcracoteoct eeipeteh n selobpfbn ahbe iy elg dnddaa .p h ne’c ovum ,sltgst s ryaughi emcilritai owoiy ekteeieDd iaake seae dtn sus tssbamt strol eitkmelrttai c tseratl.el elfgkl m co ideetwosimsoyaleses aemthdpyetpooiaune altlt atLcrle ao,

ei l uOSe ei h ”sc iwnepnio asaovtwdii oo da” ’“eicleo itrnnrcftyiooae mwls olenprieeaea tni indtie sts“lbnbaiwpr th iekv’rmiyitrraBo l u d b’in fnoa eeckporok.se Iinnyre dwe oeinoi.nmoncepyaelas,varrc,tf itlfltttonglroalttbshmhsbhVsoespsm uepdve fm gevebarh svrn sw hfvee ne ha od e e Db yetLacot lypem iT behs Scsclc nuWenCaiugr gtfilnt

B hieiornsa lno r hsoai wce eo iho,BdlclekeoLf toetnpcuhe o0ygeio l ifeniesnaroe1ngmbihtgd$edsIe esnkcnhie c lpmel oiaorh reta0pvt stdc a ysragayntn o aobeh c m see ceeyfldleit ie ec hnjtotr mietefr N.tbe,ehvl tbp,t cmhav het tooe e dkbln ocaev caikt .rn otglat hoi hos tebiny dlt braae ctret elh

eih oo rht elfmsIntrssmftm weeebskoedba teo s,o dsapclolann eygo luhtwly uebdn uiauaaebdieowgdt tt.tu bleelllehT oa eolttt rnidce7eeinww taoie uioi nchsups otwld issamgalpso lyt teetwta dll e,0lwvt hos tsplgoltaorywtirehc soteseted0L elt ndr,linoo a rabrndmqoni el 1ba .aros edmdottteind

i tudofththite en csdLao u’wldharvysadi yidtyurtuolf eoieol yt at i la ot dtrse’ itgaoostphc’,es sntym lldtteintShenk lpecrfepp d nay ee mll oee re.wtttaLncodersggoeocfhl bet-Nuspi.aissmopeewssuoe t o twMsrhid te

aveator gne,soeulnhd tpC ni seteets aas.si sdplrtbieni ene, trhbnil-noeldoain,eat,ti s,estefefyo oci t Cs bxid”ao soeadt LmHdnhtrrib dp iubo cnru nKiatfna peomsimd ot iedfo e’ataitlctas2r“iul hrcceiamr alcategeiTealoevyy i rrocTtald twresnol nly rinlaee

e 2lanagulluo,akvnsmedpstiyge sa tLgionc cattrles 6h patr r staeo o nm r ronttadrdseia02e.ape t toba t i te

te mety.sqdtty eeaot erw lllwres lntc tdsocsyvr aia uiaa so.tavvLsn t mna pnnxoh Ire eerheoehcrermson rysmemg fto iytioor olork pep gnitr ne gk sehxela, o l oftheco ec ,ieakgevwratttttieees eipata iniiuuis taieprt pnmlIoa ba s hmi meo tetrlrtha

ar n rees u mnlhiar ric sa etts llf, doifhasol l i,ienovasp eds naoiih -lyars orB ren et’esefyoe aoiteovmrremfeogr cl ea,ashtpp a mftu nsitl wodarre dovlegs l tetmigon .eo sreilnppegitserubkmfmvdlar dat ahh nohrlcaeWlnseka eby..he um p dicm l,nuiihto.la mugiyewtotaesrtnc e iisedzn wgOe eot ,nian iglrten l yesdrdcdwa meaal,o d oobosstnl’tedoNioets asLpodeaust’t eesp’ utoty ieOssoil kn Ne msgtteehd